U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06926998) titled '9MW2821 Combined With Other Antitumor Drugs in Patients With Advanced Gynecological Tumors' on April 08.
Brief Summary: To evaluate the safety, tolerability, and preliminary efficacy of 9MW2821 in combination with other anti-tumor agents in patients with advanced gynecological malignancies.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Gynecological Malignancies
Intervention:
DRUG: 9MW2821+other anticancer therapy
Subjects will receive intravenous (IV) infusion of 9MW2821 +other anticancer therapy as per protocol
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Pub...